- Home
- NERV vs TII Comparison
NERV vs TII Comparison
Compare NERV & TII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NERV | TII |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.4M | 198.5M |
| IPO Year | 2014 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NERV | TII |
|---|---|---|
| Price | $2.33 | $1.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $10.33 | $6.50 |
| AVG Volume (30 Days) | 179.3K | ★ 194.3K |
| Earning Date | 11-06-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,175,600.00 | N/A |
| Revenue This Year | N/A | $22.91 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $25.66 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.96 | $1.71 |
| 52 Week High | $8.80 | $5.65 |
Technical Indicators
Market Signals| Indicator | NERV | TII |
|---|---|---|
| Relative Strength Index (RSI) | 39.95 | 33.60 |
| Support Level | $1.96 | N/A |
| Resistance Level | $2.65 | $2.47 |
| Average True Range (ATR) | 0.24 | 0.13 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 42.50 | 15.18 |
Price Performance
Historical ComparisonAbout NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.
About TII Titan Mining Corporation
Titan Mining Corp is a Canadian natural resources company. The company is engaged in the acquisition, exploration, development, and extraction of mineral properties. The company owns an interest in the Empire State Mine in Northern New York State, United States, and Kilbourne Graphite Project. The Company operates one reportable segment, mineral production and exploration in the United States.